Mark Milner, MD
Eye Center of Southern Connecticut / New Haven, CT
Mark S. Milner, M.D. is a board-certified ophthalmologist and a fellowship-trained corneal surgeon. Dr. Milner received his bachelor of science degree from Union College and his doctor of medicine degree from the State University of New York Health Science Center, Syracuse, NY. He interned in internal medicine at Robert Wood Johnson University Hospital, New Brunswick, NJ, and completed his residency in ophthalmology at the New York Eye and Ear Infirmary. His fellowship in cornea, external disease and uveitis was completed at the prestigious Francis I. Proctor Foundation at the University of California, San Francisco.
Dr. Milner is an Associate Clinical Professor at Yale University Medical School, Department of Ophthalmology. He is both a co-founder and co-medical Director of Precision LASIK Group, Cheshire, CT. He previously held the positions of Director of the Cornea Clinic at The Veterens Administration Medical Center in West Haven, CT and the Medical Director of Education for Sunrise Technologies.
Dr. Milner is actively involved in research. He has been a principle investigator for several studies for FDA approval including, but not limited to, 32 spot Laser Thermal Keratoplasty (LTK) with Sunrise Holium Laser, the effects of diquafasol tetrasodium ophthalmic solution on subjects with dry eye syndrome, the safety and efficacy of Azithromycin ophthalmic solution in the treatment of blepharitis, and the safety and efficacy of two different topical ophthalmic solutions, EBI-005 and KPI-121 for the treatment of dry eye disease. He has authored various publications, including a 44 page peer reviewed article in Current Opinion in Ophthalmology (January 2017) detailing his innovative algorithm and approach to the diagnosis and treatment of dry eye disease, and has been interviewed by several magazines, newspaper, radio and television shows about his refractive and corneal expertise. Recently, he was featured in an article as the only ophthalmologist between NY and Boston to perform the IMT (Implantable Miniature Telescope) surgery for patients with advanced macular degeneration and blindness. He was awarded with the Yale Department of Ophthalmology Teaching Award for “Excellence in Teaching” in 1998 and was voted a “Top Doctor” in 2009, 2010, 2011, 2012, 2013, 2014 and 2015 in Connecticut Magazine by his peers. In 2016 he was selected on the list of Ocular Surgery News (OSN) Premier Surgeon 300 as one of the top 300 premier surgeons and leading innovators in the U.S. in the field of refractive cataract surgery. Dr. Milner specializes in cornea, external diseases, refractive surgery and uveitis, with a focused interest in dry eye disease and dysfunctional tear syndrome. He has built a large “dry eye” practice and has lectured throughout the world teaching other physicians about dysfunctional tear syndrome and his innovative approach, algorithm and treatments. Dr. Milner is one of the first physicians in the northeast to perform the newly approved corneal collagen cross-linking procedure (CXL) with the only FDA approved Avedro device.
Dr. Milner is a Fellow of the American College of Surgeons and is a member of the American Board of Ophthalmology, the American Medical Association, the International Society of Refractive Surgery, the American Society of Cataract and Refractive Surgery, the Connecticut Society of Eye Physicians, the New Haven County Medical Society and is a founding member of The CEDARS/ASPENS Society (Cornea External Diseases and Refractive Surgery).